SPI Pharma Introduces Valens™ Brand to Support Strategic Product Expansions Focused on Parenteral Dose Forms, Vaccine Ingredients, Adjuvants, and Adjuvant Systems

WILMINGTON, Del., July 24, 2024 /PRNewswire-PRWeb/ -- SPI Pharma introduces Valens™ as a new portfolio brand name grouping product offerings positioned to serve the vaccine, parenteral dosage form, and biologic drug market spaces. SPI's Valens™ brand will initially group together SPI...